Role of Glycolysis in PHD2/HIF-Iα-Mediated Chondrocyte Differentiation

被引：0
|
作者：
Wilsonsanthoshkumar, Aruni [1 ]
Pourteymoor, Sheila [1 ]
Mohan, Subburaman [2 ]
机构：
[1] VA Loma Linda Healthcare Syst, Loma Linda, CA USA
[2] Loma Linda Univ, VA Loma Linda Healthcare Syst, Loma Linda, CA 92350 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-0254
引用
收藏
页码：344 / 345
页数：2
相关论文
共 50 条
  • [21] Polyglobulia related to PHD2 mutations : identification of new mutants and different HIF deregulation mechanisms
    Ugo, Valerie
    HEMATOLOGIE, 2012, 18 (01): : 15 - 17
  • [22] Hepatic PHD2/HIF-1 axis is involved in postexercise systemic energy homeostasis
    Luo, Beibei
    Xiang, Dao
    Wu, Die
    Liu, Changcheng
    Fang, Yiqun
    Chen, Peijie
    Hu, Yi-Ping
    FASEB JOURNAL, 2018, 32 (09): : 4670 - 4680
  • [23] A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove
    Percy, Melanie J.
    Furlow, Paul W.
    Beer, Philip A.
    Lappin, Terence R. J.
    McMullin, Mary Frances
    Lee, Frank S.
    BLOOD, 2007, 110 (06) : 2193 - 2196
  • [24] Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival
    Andersen, Sigve
    Donnem, Tom
    Stenvold, Helge
    Al-Saad, Samer
    Al-Shibli, Khalid
    Busund, Lill-Tove
    Bremnes, Roy M.
    PLOS ONE, 2011, 6 (08):
  • [25] Regulation of PHD2 by HIF-1α in Erythroid Cells: Insights into Erythropoiesis Under Hypoxia
    Wang, Shunjuan
    Xu, Qiying
    Liu, Wenjing
    Zhang, Na
    Qi, Yuelin
    Tang, Feng
    Ge, Rili
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [26] Mir-17∼92 Regulates Hif Activity Through Targeting Phd2 In Pasmc
    Chen, T.
    Zhou, Q.
    Tang, H.
    Yuan, J. J.
    Raj, J. U.
    Zhou, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [27] Localized, siRNA-Mediated Silencing of PHD2 to Promote Wound Vascularization
    Martin, John R.
    Nelson, Christopher E.
    Gupta, Mukesh K.
    Yu, Fang
    Guelcher, Scott A.
    Davidson, Jeffrey M.
    Duvall, Craig L.
    MOLECULAR THERAPY, 2015, 23 : S194 - S195
  • [28] ACTIVATION OF HIF BY SMALL MOLECULE INHIBITORS OF PHD2 IMPROVES HEALING OF CUTANEOUS WOUNDS AND CALVARIAL DEFECTS
    Hu, M. S.
    Barnes, L. A.
    Hong, W.
    Xie, M.
    Tang, S.
    Rennert, R. C.
    Gurtner, G. C.
    Giaccia, A. J.
    Lorenz, H. P.
    Ding, S.
    Longaker, M. T.
    WOUND REPAIR AND REGENERATION, 2016, 24 (02) : A11 - A11
  • [29] An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α
    Nepal, Manoj
    Gong, Young-Dae
    Park, Young Ran
    Soh, Yunjo
    CELL BIOCHEMISTRY AND FUNCTION, 2011, 29 (02) : 126 - 134
  • [30] PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies
    Fielding, James W.
    Hodson, Emma J.
    Cheng, Xiaotong
    Ferguson, David J. P.
    Eckardt, Luise
    Adam, Julie
    Lip, Philomena
    Maton-Howarth, Matthew
    Ratnayaka, Indrika
    Pugh, Christopher W.
    Buckler, Keith J.
    Ratcliffe, Peter J.
    Bishop, Tammie
    JOURNAL OF PHYSIOLOGY-LONDON, 2018, 596 (18): : 4393 - 4412
12345